BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9045547)

  • 21. Active management of the third stage of labor among American Indian women.
    Fenton JJ; Baumeister LM; Fogarty J
    Fam Med; 2005 Jun; 37(6):410-4. PubMed ID: 15933913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of the third stage of labor.
    Dagli AC
    J Fam Pract; 1998 Jun; 46(6):452-3. PubMed ID: 9638101
    [No Abstract]   [Full Text] [Related]  

  • 23. Oxytocin in parturients with cardiac disease.
    Tamhane P; O'Sullivan G; Reynolds F
    Int J Obstet Anesth; 2006 Oct; 15(4):332-3; author reply 333. PubMed ID: 16774825
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of umbilical vein oxytocin on blood loss and length of third stage of labour.
    Shrestha P; Babu CS
    Nepal Med Coll J; 2007 Sep; 9(3):176-8. PubMed ID: 18092435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison the effects of oxytocin and methylergonovine in elective caesarean section under spinal anesthesia.
    Anvaripour A; Shahryari H; Ahmadi S; Ghasemi S; Mirzaei K
    Arch Gynecol Obstet; 2013 May; 287(5):979-83. PubMed ID: 23250341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The intramuscular use of oxytocic agents for prophylactic management of the third stage of labour.
    Djahanbakhch O; Vere M; Gardner NH; Morris EC
    Br J Clin Pract; 1978 May; 32(5):137-8. PubMed ID: 307397
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimization of third-stage management after second-trimester medical pregnancy termination.
    Dickinson JE; Doherty DA
    Am J Obstet Gynecol; 2009 Sep; 201(3):303.e1-7. PubMed ID: 19632665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effect of the Combined Use of Methylergonovine and Oxytocin during Caesarean Section in the Prevention of Post-partum Haemorrhage.
    Şentürk Ş; Kağıtçı M; Balık G; Arslan H; Kır Şahin F
    Basic Clin Pharmacol Toxicol; 2016 May; 118(5):338-43. PubMed ID: 26449959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterotonic Medications: Oxytocin, Methylergonovine, Carboprost, Misoprostol.
    Vallera C; Choi LO; Cha CM; Hong RW
    Anesthesiol Clin; 2017 Jun; 35(2):207-219. PubMed ID: 28526143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of postpartum blood loss after misoprostol-induced labour.
    ElSedeek MSh; Awad EE; ElSebaey SM
    BJOG; 2009 Feb; 116(3):431-5. PubMed ID: 19187376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of prophylactic use of 15-methyl prostalglandin F2alpha in the active management of third stage of labour.
    Biswas A; Bal R; Kundu MK; Kyal A; Halder M
    J Indian Med Assoc; 2007 Sep; 105(9):506, 508-9. PubMed ID: 18338474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial.
    Davies GA; Tessier JL; Woodman MC; Lipson A; Hahn PM
    Obstet Gynecol; 2005 Feb; 105(2):294-9. PubMed ID: 15684155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of postpartum blood loss after misoprostol-induced labour.
    Majoko F
    BJOG; 2009 Oct; 116(11):1533-4; author reply 1534-5. PubMed ID: 19769754
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of methergine for the prevention of postoperative endometritis in non-elective cesarean section patients.
    Dweck MF; Lynch CM; Spellacy WN
    Infect Dis Obstet Gynecol; 2000; 8(3-4):151-4. PubMed ID: 10968597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active versus expectant management of third stage of labour: the Hinchingbrooke randomised controlled trial.
    Rogers J; Wood J; McCandlish R; Ayers S; Truesdale A; Elbourne D
    Lancet; 1998 Mar; 351(9104):693-9. PubMed ID: 9504513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Afterpains: a comparison between active and expectant management of the third stage of labor.
    Jangsten E; Bergh I; Mattsson LÅ; Hellström AL; Berg M
    Birth; 2011 Dec; 38(4):294-301. PubMed ID: 22112329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choice of oxytocic preparation for routine use in the management of the third stage of labour: an overview of the evidence from controlled trials.
    Elbourne D; Prendiville W; Chalmers I
    Br J Obstet Gynaecol; 1988 Jan; 95(1):17-30. PubMed ID: 3277662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulprostone in the control of postpartum haemorrhage.
    Laajoki VI; Kivikoski AI
    Acta Chir Hung; 1986; 27(3):165-8. PubMed ID: 3493608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biphasic active management of the 3d stage of labor in the aspect of hemorrhage prevention in the placental period and elimination of placental retainment due to impaction].
    Durek M; Pietkiewicz D; Suchocki S
    Pol Tyg Lek; 1973 Jun; 28(23):867-8. PubMed ID: 4541697
    [No Abstract]   [Full Text] [Related]  

  • 40. Intraumbilical veinous injection oxytocin in the active management of third stage of labour.
    Tehseen F; Anwar A; Arfat Y
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):551-4. PubMed ID: 18803892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.